Repeat PSMA PET-CT Scans: — When You Need One and What It Costs

There is no single threshold that is right for everyone. EANM guidance confirms that PSMA PET-CT detects disease at lower PSA levels than conventional imaging, and that detection improves as PSA rises. What matters more than the absolute number is how fast PSA is doubling and whether a scan result would change your management. Ask your oncologist directly: if the scan showed disease, would it change what we do next? That is the question that decides the timing, not the PSA number alone.

Coverage varies between insurers and policies. Some plans cover diagnostic imaging with a valid prescription; others require pre-authorisation or limit the number of imaging studies per year. Check your policy document under PET-CT specifically. Ask the CION centre to prepare a detailed clinical justification for each scan — that documentation is typically what insurers require when processing a claim. Any out-of-pocket cost will be confirmed at booking.

PSMA PET-CT involves a small radiation dose from both the tracer and the CT component. The dose from a single scan is low, and repeat scanning over months or years is considered clinically acceptable when the scans are genuinely indicated. Your oncologist will only order a repeat scan when the information it provides is expected to change your management — that clinical gate is the main safeguard. If you are concerned about cumulative dose, ask your team to explain the dose from your specific scan and how it compares with other investigations you have already had.

No visible change on a repeat PSMA PET-CT is generally reassuring — it suggests disease is not growing or spreading in a way the scan can detect. It does not guarantee no cancer is present, because very small deposits may be below the limit of detection. If your PSA is still rising despite stable imaging, your oncologist will interpret both pieces of information together rather than relying on the scan alone. Always ask for the scan result to be explained alongside your PSA trend.

A repeat PSMA PET-CT requires a prescription from your treating oncologist or urologist — it cannot be arranged directly with the imaging centre. This is because the result needs to be interpreted alongside your full clinical history, and because tracer administration requires a supervising physician. If you are being treated at CION, your care team will arrange the scan when it is indicated and coordinate the booking with the partner imaging centre, including confirming tracer availability before your slot is fixed.

Your radiologist and oncologist compare the repeat scan directly against the first — looking at whether lesions that appeared before have grown, shrunk, or gone, and whether new ones have appeared elsewhere. That comparison is the purpose of the scan. To make it reliable, the same tracer and broadly similar preparation are used each time. Having your previous scan images and reports available at the same centre makes the comparison more accurate; if earlier scans were done elsewhere, bring those reports or ask your team to obtain them.